Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002433246 | SCV002742483 | pathogenic | Hereditary cancer-predisposing syndrome | 2019-06-19 | criteria provided, single submitter | clinical testing | The c.2544_2551delCCTGGAAC pathogenic mutation, located in coding exon 15 of the MSH2 gene, results from a deletion of 8 nucleotides at nucleotide positions 2544 to 2551, causing a translational frameshift with a predicted alternate stop codon (p.L849*). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |